Xilong Scientific Co., Ltd.

SZSE:002584 Stock Report

Market Cap: CN¥4.1b

Xilong Scientific Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Xilong Scientific.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals earnings growth29.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Apr 01

Investors Will Want Xilong Scientific's (SZSE:002584) Growth In ROCE To Persist

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analysis Article • Nov 27

Some Shareholders Feeling Restless Over Xilong Scientific Co., Ltd.'s (SZSE:002584) P/E Ratio

With a price-to-earnings (or "P/E") ratio of 75.9x Xilong Scientific Co., Ltd. ( SZSE:002584 ) may be sending very...
Analysis Article • Sep 30

Here's What To Make Of Xilong Scientific's (SZSE:002584) Decelerating Rates Of Return

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysis Article • Jun 07

Xilong Scientific (SZSE:002584) Will Want To Turn Around Its Return Trends

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analysis Article • Apr 22

Xilong Scientific Co., Ltd. (SZSE:002584) Not Doing Enough For Some Investors As Its Shares Slump 26%

The Xilong Scientific Co., Ltd. ( SZSE:002584 ) share price has fared very poorly over the last month, falling by a...
Analysis Article • Mar 08

Xilong Scientific Co., Ltd. (SZSE:002584) Surges 35% Yet Its Low P/S Is No Reason For Excitement

Those holding Xilong Scientific Co., Ltd. ( SZSE:002584 ) shares would be relieved that the share price has rebounded...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Xilong Scientific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:002584 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20267,430-72-344-239N/A
12/31/20257,331-75-3169N/A
9/30/20257,150-64375420N/A
6/30/20257,232-56410453N/A
3/31/20257,60563322377N/A
12/31/20247,81662257302N/A
9/30/20247,29168-62-4N/A
6/30/20247,37364-1928N/A
3/31/20247,08930-333-266N/A
12/31/20237,09233-500-285N/A
9/30/20237,71730-461-84N/A
6/30/20237,21631-809-369N/A
3/31/20236,75020-683-217N/A
1/1/20236,18389-515-191N/A
9/30/20224,778119-1912N/A
6/30/20224,78512644176N/A
3/31/20225,169252283343N/A
1/1/20225,380187316373N/A
9/30/20216,599170503525N/A
6/30/20216,197163600623N/A
3/31/20216,51578344383N/A
12/31/20206,24357645N/A
9/30/20205,50959-207-174N/A
6/30/20204,99349-162-128N/A
3/31/20203,7135199114N/A
12/31/20193,33839N/A96N/A
9/30/20193,09317N/A-341N/A
6/30/20193,25239N/A-354N/A
3/31/20193,61044N/A-280N/A
12/31/20183,35571N/A-97N/A
9/30/20183,511103N/A52N/A
6/30/20183,444101N/A10N/A
3/31/20183,35193N/A-56N/A
12/31/20173,30590N/A-19N/A
9/30/20173,57277N/A25N/A
6/30/20173,42277N/A32N/A
3/31/20173,16687N/A36N/A
12/31/20162,92897N/A11N/A
9/30/20162,641100N/A117N/A
6/30/20162,53198N/A39N/A
3/31/20162,49594N/A30N/A
12/31/20152,51491N/A129N/A
9/30/20152,22492N/A59N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002584's forecast earnings growth is above the savings rate (2.4%).

Earnings vs Market: Insufficient data to determine if 002584's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002584's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002584's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002584's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 002584's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/30 18:27
End of Day Share Price 2026/07/30 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xilong Scientific Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ye Hui YangHuatai Research
Fangbiao ZhengIndustrial Securities Co. Ltd.
Zhu Bing YanPing An Securities Co. Ltd.